Close Menu

NEW YORK – The US Food and Drug Administration this week issued a draft guidance for a new voluntary pathway that it anticipates will "significantly improve" the safety of available treatments or diagnostic devices for diseases or conditions that are less serious than those eligible for the agency’s Breakthrough Devices Program.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.